Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy-Reference-Cited by-同舟云学术

Remacemide hydrochloride: a placebo-controlled, one month, double-blind assessment of its safety, tolerability and pharmacokinetics as adjunctive therapy in patients with epilepsy

Published:2000-12 Issue:8 Volume:9 Page:544-550
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Chadwick D.,Smith D.,Crawford P.,Harrison B.

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference6 articles.

1. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro;Palmer;Archives Internationales de Pharmacodynamie et de Therapie,1992

2. Preclinical and clinical aspects of remacemide hydrochloride;Palmer,1997

3. A double-blind placebo controlled cross-over study of remacemide hydrochloride as adjunctive therapy in patients with refractory epilepsy;Crawford;Epilepsy,1992

4. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites;Leach;Epilepsia,1996

5. Mutual interaction between remacemide hydrochloride and phenytoin;Leach;Epilepsy Research,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Remacemide;Meyler's Side Effects of Drugs;2016

2. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions;Pharmacological Reports;2009-03

3. Pharmacokinetic Optimisation in the Treatment of Parkinson???s Disease;Clinical Pharmacokinetics;2006

4. Remacemide;Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions;2006

5. Assessing the potential toxicity of MK-801 and remacemide:;Neurotoxicology and Teratology;2002-03